BRIGHT MINDS BIOSCIENCES INC. - DRUG
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 22
Latest filed: Jun 03, 2026
| Form | Count |
|---|---|
| 6-K | 12 |
| SCHEDULE 13G/A | 8 |
| SCHEDULE 13G | 1 |
| 4 | 1 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Jun 03, 2026 | 6-K | Mar 31, 2026 | 0001062993-26-003005 | View |
| Jun 02, 2026 | 6-K | Jan 20, 2026 | 0001062993-26-002975 | View |
| May 28, 2026 | 6-K | May 26, 2026 | 0002060755-26-000031 | View |
| May 20, 2026 | 6-K | Mar 31, 2026 | 0001062993-26-002801 | View |
| May 15, 2026 | SCHEDULE 13G | — | 0000902664-26-002546 | View |
| May 15, 2026 | SCHEDULE 13G/A | — | 0001274173-26-000134 | View |
| May 15, 2026 | SCHEDULE 13G/A | — | 0001274173-26-000135 | View |
| May 12, 2026 | SCHEDULE 13G/A | — | 0001213900-26-055371 | View |
| Apr 30, 2026 | 4 | Apr 28, 2026 | 0000929638-26-001708 | View |
| Apr 30, 2026 | SCHEDULE 13G/A | — | 0000929638-26-001709 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | — | 0001193125-26-054519 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | — | 0001831942-26-000007 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | — | 0001274173-26-000081 | View |
| Feb 13, 2026 | 6-K | Dec 31, 2025 | 0001062993-26-000881 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | — | 0001172661-26-000518 | View |
| Jan 09, 2026 | 6-K | Jan 07, 2026 | 0001062993-26-000138 | View |
| Jan 09, 2026 | 6-K | Jan 09, 2026 | 0001062993-26-000151 | View |
| Jan 08, 2026 | 6-K | Jan 07, 2026 | 0002060755-26-000009 | View |
| Jan 07, 2026 | 6-K | Jan 06, 2026 | 0002060755-26-000007 | View |
| Jan 07, 2026 | 6-K | Jan 07, 2026 | 0001062993-26-000102 | View |
| Jan 06, 2026 | 6-K | Jan 06, 2026 | 0002060755-26-000005 | View |
| Jan 05, 2026 | 6-K | Jan 05, 2026 | 0002060755-26-000002 | View |